{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:27:03Z","timestamp":1790872023562,"version":"4.1.0"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T00:00:00Z","timestamp":1633651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>\n                    <jats:bold>Objective:<\/jats:bold>\n                    To study the clinical characteristics and treatment of pediatric opsoclonus-myoclonus syndrome (OMS).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods:<\/jats:bold>\n                    We analyzed the clinical data of nine children OMS between June 2017 and Nov 2020.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    Nine children (M\/F = 3:6, median onset age was 18 months) diagnosed with OMS were included in the study. Before onset, human rhinovirus and respiratory syncytial virus were seen in one patient, respectively. And one patient received Japanese encephalitis vaccination. Three patients had neuroblastoma, and one patient had ganglioneuroblastoma. All patients' symptoms were improved after receiving surgery (for four patients with tumor), intravenous human immunoglobulin and pulsed methylprednisolone. However, four patients without mass relapsed and became relapse free after rituximab treatment. The relapse rate was 44.4% (4\/9). The OMS severity score at the last follow-up was significantly lower than the OMS severity score at onset (3.0 \u00b1 1.0 vs. 11.0 \u00b1 2.2, paired-samples\n                    <jats:italic>t<\/jats:italic>\n                    -test,\n                    <jats:italic>P<\/jats:italic>\n                    &amp;lt; 0.001). All patients had at least one item of neurological symptoms or neuropsychological disturbances.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion:<\/jats:bold>\n                    For pediatric OMS, human rhinovirus infection and respiratory syncytial virus infection can be seen before onset. Rituximab is effective in reducing relapse. Improving recognition and long-term prognosis in OMS is urgent.\n                  <\/jats:p>","DOI":"10.3389\/fneur.2021.744041","type":"journal-article","created":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T10:42:36Z","timestamp":1633862556000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Clinical Analysis of Pediatric Opsoclonus-Myoclonus Syndrome in One of the National Children's Medical Center in China"],"prefix":"10.3389","volume":"12","author":[{"given":"Haixia","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianfeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiru","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiling","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yani","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingwei","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Xiong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,10,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ejpn.2009.03.002","article-title":"A prospective study of the presentation and management of dancing eye syndrome\/opsoclonus-myoclonus syndrome in the United Kingdom","volume":"14","author":"Pang","year":"2010","journal-title":"Eur J Paediatr Neurol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.braindev.2014.10.010","article-title":"A nationwide survey of opsoclonus-myoclonus syndrome in Japanese children","volume":"37","author":"Hasegawa","year":"2015","journal-title":"Brain Dev."},{"key":"B3","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.canlet.2005.01.051","article-title":"Opsoclonus myoclonus syndrome in neuroblastoma a report from a workshop on the dancing eyes syndrome at the advances in neuroblastoma meeting in Genoa, Italy, 2004","volume":"228","author":"Matthay","year":"2005","journal-title":"Cancer Lett."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1002\/pbc.22226","article-title":"Improvement of neurological status and quality of life in children with opsoclonus myoclonus syndrome at long-term follow-up","volume":"53","author":"Catsman-Berrevoets","year":"2009","journal-title":"Pediatr Blood Cancer."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e388","DOI":"10.1542\/peds.2010-3114","article-title":"Outcome and prognostic features in opsoclonus-myoclonus syndrome from infancy to adult life","volume":"128","author":"Brunklaus","year":"2011","journal-title":"Pediatrics."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1111\/dmcn.14628","article-title":"IQ predictors in pediatric opsoclonus myoclonus syndrome. A large international cohort study","volume":"62","author":"Sheridan","year":"2020","journal-title":"Dev Med Child Neurol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1097\/MOP.0b013e32833fde3f","article-title":"Update on diagnosis, treatment, prognosis in opsoclonus-myoclonus-ataxia syndrome","volume":"22","author":"Gorman","year":"2010","journal-title":"Curr Opin Pediatr."},{"key":"B8","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1177\/0883073814549581","article-title":"Effect of increased immunosuppression on developmental outcome of Opsoclonus Myoclonus Syndrome (OMS)","volume":"30","author":"Mitchell","year":"2015","journal-title":"J Child Neurol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"468","DOI":"10.3389\/fneur.2017.00468","article-title":"Clinical immunologic features of 389 children with opsoclonus-myoclonus syndrome: a cross-sectional study","volume":"8","author":"Pranzatelli","year":"2017","journal-title":"Front Neurol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1177\/1043454204272560","article-title":"Neuroepidemiologic trends in 105 US cases of pediatric opsoclonus-myoclonus syndrome","volume":"22","author":"Tate","year":"2005","journal-title":"J Pediatr Oncol Nurs."},{"key":"B11","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.ejpn.2009.12.005","article-title":"Opsoclonus-myoclonus in children associated or not with neuroblastoma","volume":"14","author":"Krug","year":"2010","journal-title":"Eur J Paediatr Neurol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1177\/0883073811428816","article-title":"Active comparator-controlled, rater-blinded study of corticotropin-based immunotherapies for opsoclonus-myoclonus syndrome","volume":"27","author":"Tate","year":"2012","journal-title":"J Child Neurol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1212\/WNL.0000000000000570","article-title":"Utility safety of rituximab in pediatric autoimmune inflammatory CNS disease","volume":"83","author":"Dale","year":"2014","journal-title":"Neurology."},{"key":"B14","doi-asserted-by":"publisher","first-page":"864","DOI":"10.3389\/fneur.2018.00864","article-title":"Opsoclonus-myoclonus syndrome associated with west-nile virus infection: case report and review of the literature","volume":"9","author":"Radu","year":"2018","journal-title":"Front Neurol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s13365-016-0470-3","article-title":"Adult-onset opsoclonus-myoclonus syndrome due to West Nile Virus treated with intravenous immunoglobulin","volume":"23","author":"H\u00e9bert","year":"2017","journal-title":"J Neurovirol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.ejpn.2018.05.002","article-title":"Acute transverse myelitis following an opsoclonus-myoclonus syndrome: an unusual presentation","volume":"22","author":"Simon","year":"2018","journal-title":"Eur J Paediatr Neurol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jns.2014.04.013","article-title":"Opsoclonus-myoclonus syndrome associated with human herpes virus-6 rhomboencephalitis","volume":"341","author":"Belcastro","year":"2014","journal-title":"J Neurol Sci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1212\/WNL.58.7.1131","article-title":"Opsoclonus-myoclonus syndrome following Epstein-Barr virus infection","volume":"58","author":"Verma","year":"2002","journal-title":"Neurology."},{"key":"B19","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1186\/s40064-015-1429-1","article-title":"Opsoclonus-myoclonus syndrome after adenovirus infection","volume":"4","author":"Syrbe","year":"2015","journal-title":"Springerplus."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.2169\/internalmedicine.51.7627","article-title":"Opsoclonus-myoclonus syndrome following influenza a infection","volume":"51","author":"Morita","year":"2012","journal-title":"Intern Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"211","DOI":"10.4103\/0972-2327.70876","article-title":"Opsoclonus-myoclonus syndrome caused by varicella-zoster virus","volume":"13","author":"Singh","year":"2010","journal-title":"Ann Indian Acad Neurol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e86","DOI":"10.1111\/ped.12433","article-title":"Opsoclonus-myoclonus syndrome following rotavirus gastroenteritis","volume":"56","author":"Gurkas","year":"2014","journal-title":"Pediatr Int."},{"key":"B23","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1080\/00207454.2020.1737531","article-title":"Opsoclonus-myoclonus syndrome associated with herpes simplex virus infection: a case report","volume":"131","author":"Chen","year":"2020","journal-title":"Int J Neurosci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s00431-009-1105-y","article-title":"Correspondence: a further case of opsoclonus-myoclonus syndrome associated with Mycoplasma pneumoniae infection","volume":"169","author":"Shiihara","year":"2010","journal-title":"Eur J Pediatr."},{"key":"B25","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00431-009-1048-3","article-title":"Mycoplasma pneumoniae associated opsoclonus-myoclonus syndrome in three cases","volume":"169","author":"Huber","year":"2010","journal-title":"Eur J Pediatr."},{"key":"B26","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jns.2011.03.012","article-title":"Opsoclonus-myoclonus syndrome associated with Mycoplasma pneumoniae infection in an elderly patient","volume":"305","author":"Nunes","year":"2011","journal-title":"J Neurol Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1055\/s-0031-1283109","article-title":"Adult opsoclonus-myoclonus syndrome following Mycoplasma pneumoniae infection with dramatic response to plasmapheresis","volume":"111","author":"Mesraoua","year":"2011","journal-title":"Acta Neurol Belg."},{"key":"B28","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.parkreldis.2009.04.002","article-title":"Opsoclonus Myoclonus after human papilloma virus vaccine in a pediatric patient","volume":"15","author":"McCarthy","year":"2009","journal-title":"Parkinsonism Relat Disord."},{"key":"B29","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1353-8020(00)00020-1","article-title":"Post-vaccinic opsoclonus-myoclonus syndrome: a case report","volume":"6","author":"Lapenna","year":"2000","journal-title":"Parkinsonism Relat Disord."},{"key":"B30","doi-asserted-by":"publisher","first-page":"229","DOI":"10.2741\/s511","article-title":"A protocol for investigating the association of vaccination and anti-NMDA receptor encephalitis","volume":"10","author":"Wang","year":"2018","journal-title":"Front Biosci (Schol Ed)"},{"key":"B31","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1177\/088307389000500217","article-title":"Opsoclonus-ataxia due to childhood neural crest tumors: a chronic neurologic syndrome","volume":"5","author":"Mitchell","year":"1990","journal-title":"J Child Neurol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1136\/adc.2010.204792","article-title":"Investigating neuroblastoma in childhood opsoclonus-myoclonus syndrome","volume":"97","author":"Brunklaus","year":"2012","journal-title":"Arch Dis Child."},{"key":"B33","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S2352-4642(17)30130-X","article-title":"Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomised, open-label, phase 3 trial","volume":"2","author":"de Alarcon","year":"2018","journal-title":"Lancet Child Adolesc Health."},{"key":"B34","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1080\/14737175.2016.1176914","article-title":"Childhood opsoclonus-myoclonus syndrome: diagnosis and treatment","volume":"16","author":"Blaes","year":"2016","journal-title":"Expert Rev Neurother."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1212\/WNL.62.9.1526","article-title":"B- and T-cell markers in opsoclonus-myoclonus syndrome: immunophenotyping of CSF lymphocytes","volume":"62","author":"Pranzatelli","year":"2004","journal-title":"Neurology."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.1542\/peds.2004-0845","article-title":"Immunologic and clinical responses to rituximab in a child with opsoclonus-myoclonus syndrome","volume":"115","author":"Pranzatelli","year":"2005","journal-title":"Pediatrics."},{"key":"B37","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s00431-006-0247-4","article-title":"Long-term outcome of ten children with opsoclonus-myoclonus syndrome","volume":"166","author":"Klein","year":"2007","journal-title":"Eur J Pediatr."},{"key":"B38","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3390\/children7090103","article-title":"Evolving cognitive dysfunction in children with neurologically stable opsoclonus-myoclonus syndrome","volume":"7","author":"Goh","year":"2020","journal-title":"Children (Basel)"},{"key":"B39","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1002\/mds.20125","article-title":"CSF B-cell expansion in opsoclonus-myoclonus syndrome: a biomarker of disease activity","volume":"19","author":"Pranzatelli","year":"2004","journal-title":"Mov Disord."},{"key":"B40","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.pediatrneurol.2011.02.012","article-title":"Cerebrospinal fluid oligoclonal bands in childhood opsoclonus-myoclonus","volume":"45","author":"Pranzatelli","year":"2011","journal-title":"Pediatr Neurol."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.744041\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T10:42:41Z","timestamp":1633862561000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.744041\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,8]]},"references-count":40,"alternative-id":["10.3389\/fneur.2021.744041"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2021.744041","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,8]]},"article-number":"744041"}}